Parathyroidectomy Markedly Reduces Oxidative Stress in a Patient with Primary Hyperparathyroidism

Therapeutic Apheresis and Dialysis

Volumn 15, Issue SUPPL.1, 2011, Pages 38-41

  Tanaka, Motoko ^a   Tokunaga, Koki ^a   Maruyama, Toru ^a   Otagiri, Masaki ^a   Tominaga, Yoshihiro ^b   Itoh, Kazuko ^a   Matsushita, Kazutaka ^a   Komaba, Hirotaka ^c   Fukagawa, Masafumi ^c  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Oxidative stress; Oxidized albumin; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HUMAN; MORTALITY; OXIDATIVE STRESS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RISK REDUCTION;

AGED, 80 AND OVER; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; SERUM ALBUMIN;

EID: 79956207509     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2011.00925.x     Document Type: Article

References (10)

1. Hagström E, Hellman P, Larsson TE etal. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009;119:2765-71.
2. Walgenbach S, Hommel G, Junginger T. Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 2000;24:564-9.
3. Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RM, Krieger EM, De Lima JJ. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery 2007;142:699-703.
4. Taki K, Takayama F, Tsuruta Y, Niwa T. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006;70:218-24.
5. Anraku M, Kitamura K, Shinohara A etal. Intravenous iron administration induces oxidation of serum albumin in hemodialysis patients. Kidney Int 2004;66:841-8.
6. Anraku M, Kitamura K, Shintomo R etal. Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: a pilot study. Clin Biochem 2008;41:1168-74.
7. Piovesan A, Molineri N, Casasso F etal. Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol 1999;50:321-8.
8. Terawaki H, Yoshimura K, Hasegawa T etal. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004;66:1988-93.
9. Descamps LB, Witko SV, Nguyen KT etal. Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005;45:39-47.
10. Matsuyama Y, Hayashi T, Terawaki H etal. Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems. J Physiol Sci 2009;59:207-15.